ICRP Publication 52: Protection of the Patient in Nuclear Medicine
Annals of the ICRP Volume 17/4By
- . ICRP
This publication is concerned with exposures of patients resulting from the administration of radiopharmaceuticals for diagnostic, therapeutic and research purposes, including some recommendations on protection of the patient's family. The report advises on the factors that influence absorbed doses (and hence radiation risks) to patients from different types of nuclear medicine examinations and indicates ways by which these risks can be minimized without detriment to intended medical benefits. This report supersedes ICRP publication 17 and, together with ICRP publications 34 and 44, completes a series of three reports dealing with protection of the patient exposed to ionizing radiation in medicine. It should be read in conjunction with ICRP Publication 53, Radiation Dose to Patients from Radiopharmaceuticals.
For nuclear medicine physicians, radiologists, medical physicists, technologists and others concerned with the practice of nuclear medicine.
International Commission on Radiological Protection
Paperback, 46 Pages
Published: February 1988
It is closely related to Publication 53 ... between them these two reports provide a much needed update and expansion ....
NRPB, March 1989
- Introduction. Guidelines to good clinical practice. Education and training. Estimates of absorbed dose. Design of facilities, instrumentation, quality assurance and control. Radiopharmaceuticals: preparation and quality assurance. References.